Genexion Clinical Research Center - RI Providence, Providence 02906

Genexion Clinical Research Center entered the industry of Medical Labs in 2009 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 621511, which describes it as a Medical Labs. For further clarification, the SIC classifies this business under the code 8071 and described it as a Medical Labs. The business provides service to the B2C market.

To acquire more information, please contact John Gillen by calling (401) 270-4431 during business hours. You can also write to the business’ Single Location at 1 Richmond Square, Providence, Rhode Island RI 02906. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Genexion Clinical Research Center
Representative: John Gillen
Place of Business: 1 Richmond Square, Providence, RI 02906
Contact Number: (401) 270-4431
Type of Service: Medical Labs
SIC Number: 8071
NAICS Number: 621511
Locality: Single Location
Market Type: B2C (Business to Consumer)
Began: 2009
Income/Year: $100.000 to $499.999
Laborers: 1 to 4
Share This Company:

Genexion Clinical Research Center is a company operating from Providence, Rhode Island providing professional Medical Labs and relevant B2C variables. It was founded in 2009 and registered with the SIC code 8071 as Medical Labs, and with the NAICS code 621511 as Medical Labs.

With a current employee count of 1 to 4, Genexion Clinical Research Center has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative John Gillen at (401) 270-4431 for related queries, or to locate its Single Location using the coordinates 41.827105,-71.381727.

The Single Location can also be found at the street address 1 Richmond Square in Providence, Rhode Island 02906 and can be engaged online through the company website at , the company Twitter , and Facebook page .